Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Team Novo Nordisk and Colnago Extend Partnership Through 2021

Renowned Italian bike manufacturer and the world's first all-diabetes professional cycling team extend contract making Colnago the team's official bike sponsor through the 2021 season.


News provided by

Team Novo Nordisk

Jul 31, 2019, 08:15 ET

Share this article

Share toX

Share this article

Share toX

Team Novo Nordisk's David Lozano proudly showcasing the team's Colnago C64.
Team Novo Nordisk's David Lozano proudly showcasing the team's Colnago C64.

ATLANTA, July 31, 2019 /PRNewswire-PRWeb/ -- Team Novo Nordisk, the world's first all-diabetes professional cycling team, and renowned Italian bike manufacturer, Colnago, announced Wednesday the extension of Colnago serving as the team's official bike sponsor through the 2021 season. Team Novo Nordisk first raced on Colnago bikes in 2013, its first professional season, and has continuously raced on the iconic Italian brand since 2016.

"When you race against the best in the sport, you need the top, most reliable equipment. Colnago is one of the most respected bike brands in the world, which they achieved through their outstanding quality and lengthy winning history," said Team Novo Nordisk General Manager Vassili Davidenko. "We use the Concept and C64 both built to withstand the demands of the hardest races. You can fully trust these bikes on any terrain thanks to their high-quality carbon fiber and cutting-edge aero design. This makes a bike that's stiff, light and phenomenally responsive. Thanks Maestro Colnago for letting us use the most desirable bikes in the world for the coming years."

"When you race against the best in the sport, you need the top, most reliable equipment. Colnago is one of the most respected bike brands in the world, which they achieved through their outstanding quality and lengthy winning history,” said Team Novo Nordisk General Manager Vassili Davidenko. “

Post this

Team Novo Nordisk's men's professional team currently races on Colnago's C64 and Concept bikes on the road and the K-Zero during time trials. For the 2020 season, the team will transition exclusively over to the C64s for the road.

"For more than 50 years, Colnago has been one of the most innovative brands in bike racing and with the C64, they have crafted the lightest, fastest and most comfortable bike in the pro peloton," said Team Novo Nordisk CEO and Co-Founder Phil Southerland. "Colnago's iconic bikes have empowered Team Novo Nordisk athletes and the more than 437 million people living with diabetes to get outside and chase their dreams, and we look forward to keep sharing our mission to inspire, educate and empower people around the world affected by diabetes. All of us at Team Novo Nordisk are honored to ride Ernesto's bikes."

The team has had its most successful season to date with Andrea Peron (ITA) sprinting to eighth place on Stage 7 of the Tour of California, the team's best finish at a World Tour race in its seven-year history.

"We are proud and happy to continue working with Team Novo Nordisk," said Ernesto Colnago, Founder of Colnago. "Since the beginning, we have been passionate to support Team Novo Nordisk and its healthy values around sport and exercise. We are eager to watch the team continue to grow and want to send the best of luck to all the riders and staff."

Additional standouts from the 2019 season include David Lozano (ESP) taking fifth on Stage 4 of the Tour du Rwanda and going on to finish sixth overall, Charles Planet (FRA) powering to fourth in the Tour of Estonia Prologue, and Peron earning third on Stage 1, fourth on Stage 2 and eighth overall at the Tour of Estonia. Additionally, Planet wore the Intermediate Sprint Jersey four consecutive days at the UAE Tour and earned the Most Aggressive Rider jersey following a late-race solo attack on the opening stage of the Tour of California. Finally, Lozano won the overall KOM jersey at the Tour of Taiyuan after wearing the jersey from Stage 2 until the end of the six-day Chinese race.

Since 1954, Colnago has been a world leader in innovative bike design. For over 65 years, Colnago has pushed the boundaries in cycling manufacturing and is known for its stiffer, faster and lighter race bikes. In 51 years of sponsorships, the first with Molteni in 1968, Colnago has worked with more than 200 professional teams and more than 5,000 athletes.

About Team Novo Nordisk
Team Novo Nordisk is a global all-diabetes sports team of cyclists spearheaded by the world's first all-diabetes UCI Professional Continental cycling team. In 2012, Phil Southerland, co-founder and CEO of the team, and global healthcare company Novo Nordisk, came together to create Team Novo Nordisk, based on a shared vision to inspire, educate and empower people around the world affected by diabetes. For more information, go to http://www.teamnovonordisk.com.

About Colnago
Colnago is an Italian company established by Ernesto Colnago in 1954. During the last 65 years, Colnago has sponsored some of the best riders in the world. Eddy Merckx and the Molteni team, the Mapei armada and Rabobank are just some of the teams that have ridden Colnago bikes.

Media Contacts:
Fitzalan Crowe for Team Novo Nordisk
[email protected]
+1-703-596-2020

Alessandro Turci for Colnago
[email protected]

SOURCE Team Novo Nordisk

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.